StreetInsider.com News Articles

StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 04 Sep 2025 06:00:41 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday 4DMedical receives FDA clearance for CT:VQ lung imaging technology http://www.streetinsider.com/FDA/4DMedical+receives+FDA+clearance+for+CT%3AVQ+lung+imaging+technology/25294572.html <p>4DMedical Limited (ASX:4DX) received FDA 510(k) clearance for its CT:VQ technology, a non-contrast ventilation-perfusion imaging solution that converts standard chest CT scans into quantitative lung function maps.</p> <p>The U.S. Centers for Medicare & Medicaid Services confirmed reimbursement for CT:VQ under Category III CPT codes, which is additional to existing reimbursement for chest CT scans. The technology operates as software-as-a-service and integrates with existing radiology workflows through DICOM-based PACS reporting systems.</p> <p>CT:VQ works with the approximately 14,500 CT scanners installed across the United States, enabling hospitals without nuclear medicine capabilities to perform functional lung imaging. The system eliminates the need for contrast injections http://www.streetinsider.com/FDA/4DMedical+receives+FDA+clearance+for+CT%3AVQ+lung+imaging+technology/25294572.html Thu, 04 Sep 2025 06:00:41 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical receives FDA clearance for CT:VQ lung imaging technology http://www.streetinsider.com/FDA/4DMedical+receives+FDA+clearance+for+CT%3AVQ+lung+imaging+technology/25294572.html <p>4DMedical Limited (ASX:4DX) received FDA 510(k) clearance for its CT:VQ technology, a non-contrast ventilation-perfusion imaging solution that converts standard chest CT scans into quantitative lung function maps.</p> <p>The U.S. Centers for Medicare & Medicaid Services confirmed reimbursement for CT:VQ under Category III CPT codes, which is additional to existing reimbursement for chest CT scans. The technology operates as software-as-a-service and integrates with existing radiology workflows through DICOM-based PACS reporting systems.</p> <p>CT:VQ works with the approximately 14,500 CT scanners installed across the United States, enabling hospitals without nuclear medicine capabilities to perform functional lung imaging. The system eliminates the need for contrast injections http://www.streetinsider.com/FDA/4DMedical+receives+FDA+clearance+for+CT%3AVQ+lung+imaging+technology/25294572.html Thu, 04 Sep 2025 06:00:41 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical receives FDA clearance for CT:VQ lung imaging technology http://www.streetinsider.com/FDA/4DMedical+receives+FDA+clearance+for+CT%3AVQ+lung+imaging+technology/25294572.html <p>4DMedical Limited (ASX:4DX) received FDA 510(k) clearance for its CT:VQ technology, a non-contrast ventilation-perfusion imaging solution that converts standard chest CT scans into quantitative lung function maps.</p> <p>The U.S. Centers for Medicare & Medicaid Services confirmed reimbursement for CT:VQ under Category III CPT codes, which is additional to existing reimbursement for chest CT scans. The technology operates as software-as-a-service and integrates with existing radiology workflows through DICOM-based PACS reporting systems.</p> <p>CT:VQ works with the approximately 14,500 CT scanners installed across the United States, enabling hospitals without nuclear medicine capabilities to perform functional lung imaging. The system eliminates the need for contrast injections http://www.streetinsider.com/FDA/4DMedical+receives+FDA+clearance+for+CT%3AVQ+lung+imaging+technology/25294572.html Thu, 04 Sep 2025 06:00:41 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical receives FDA clearance for CT:VQ lung imaging technology http://www.streetinsider.com/FDA/4DMedical+receives+FDA+clearance+for+CT%3AVQ+lung+imaging+technology/25294572.html <p>4DMedical Limited (ASX:4DX) received FDA 510(k) clearance for its CT:VQ technology, a non-contrast ventilation-perfusion imaging solution that converts standard chest CT scans into quantitative lung function maps.</p> <p>The U.S. Centers for Medicare & Medicaid Services confirmed reimbursement for CT:VQ under Category III CPT codes, which is additional to existing reimbursement for chest CT scans. The technology operates as software-as-a-service and integrates with existing radiology workflows through DICOM-based PACS reporting systems.</p> <p>CT:VQ works with the approximately 14,500 CT scanners installed across the United States, enabling hospitals without nuclear medicine capabilities to perform functional lung imaging. The system eliminates the need for contrast injections http://www.streetinsider.com/FDA/4DMedical+receives+FDA+clearance+for+CT%3AVQ+lung+imaging+technology/25294572.html Thu, 04 Sep 2025 06:00:41 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical receives FDA clearance for CT:VQ lung imaging technology http://www.streetinsider.com/FDA/4DMedical+receives+FDA+clearance+for+CT%3AVQ+lung+imaging+technology/25294572.html <p>4DMedical Limited (ASX:4DX) received FDA 510(k) clearance for its CT:VQ technology, a non-contrast ventilation-perfusion imaging solution that converts standard chest CT scans into quantitative lung function maps.</p> <p>The U.S. Centers for Medicare & Medicaid Services confirmed reimbursement for CT:VQ under Category III CPT codes, which is additional to existing reimbursement for chest CT scans. The technology operates as software-as-a-service and integrates with existing radiology workflows through DICOM-based PACS reporting systems.</p> <p>CT:VQ works with the approximately 14,500 CT scanners installed across the United States, enabling hospitals without nuclear medicine capabilities to perform functional lung imaging. The system eliminates the need for contrast injections http://www.streetinsider.com/FDA/4DMedical+receives+FDA+clearance+for+CT%3AVQ+lung+imaging+technology/25294572.html Thu, 04 Sep 2025 06:00:41 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical receives FDA clearance for CT:VQ lung imaging technology http://www.streetinsider.com/FDA/4DMedical+receives+FDA+clearance+for+CT%3AVQ+lung+imaging+technology/25294572.html <p>4DMedical Limited (ASX:4DX) received FDA 510(k) clearance for its CT:VQ technology, a non-contrast ventilation-perfusion imaging solution that converts standard chest CT scans into quantitative lung function maps.</p> <p>The U.S. Centers for Medicare & Medicaid Services confirmed reimbursement for CT:VQ under Category III CPT codes, which is additional to existing reimbursement for chest CT scans. The technology operates as software-as-a-service and integrates with existing radiology workflows through DICOM-based PACS reporting systems.</p> <p>CT:VQ works with the approximately 14,500 CT scanners installed across the United States, enabling hospitals without nuclear medicine capabilities to perform functional lung imaging. The system eliminates the need for contrast injections http://www.streetinsider.com/FDA/4DMedical+receives+FDA+clearance+for+CT%3AVQ+lung+imaging+technology/25294572.html Thu, 04 Sep 2025 06:00:41 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical receives FDA clearance for CT:VQ lung imaging technology http://www.streetinsider.com/FDA/4DMedical+receives+FDA+clearance+for+CT%3AVQ+lung+imaging+technology/25294572.html <p>4DMedical Limited (ASX:4DX) received FDA 510(k) clearance for its CT:VQ technology, a non-contrast ventilation-perfusion imaging solution that converts standard chest CT scans into quantitative lung function maps.</p> <p>The U.S. Centers for Medicare & Medicaid Services confirmed reimbursement for CT:VQ under Category III CPT codes, which is additional to existing reimbursement for chest CT scans. The technology operates as software-as-a-service and integrates with existing radiology workflows through DICOM-based PACS reporting systems.</p> <p>CT:VQ works with the approximately 14,500 CT scanners installed across the United States, enabling hospitals without nuclear medicine capabilities to perform functional lung imaging. The system eliminates the need for contrast injections http://www.streetinsider.com/FDA/4DMedical+receives+FDA+clearance+for+CT%3AVQ+lung+imaging+technology/25294572.html Thu, 04 Sep 2025 06:00:41 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical receives FDA clearance for CT:VQ lung imaging technology http://www.streetinsider.com/FDA/4DMedical+receives+FDA+clearance+for+CT%3AVQ+lung+imaging+technology/25294572.html <p>4DMedical Limited (ASX:4DX) received FDA 510(k) clearance for its CT:VQ technology, a non-contrast ventilation-perfusion imaging solution that converts standard chest CT scans into quantitative lung function maps.</p> <p>The U.S. Centers for Medicare & Medicaid Services confirmed reimbursement for CT:VQ under Category III CPT codes, which is additional to existing reimbursement for chest CT scans. The technology operates as software-as-a-service and integrates with existing radiology workflows through DICOM-based PACS reporting systems.</p> <p>CT:VQ works with the approximately 14,500 CT scanners installed across the United States, enabling hospitals without nuclear medicine capabilities to perform functional lung imaging. The system eliminates the need for contrast injections http://www.streetinsider.com/FDA/4DMedical+receives+FDA+clearance+for+CT%3AVQ+lung+imaging+technology/25294572.html Thu, 04 Sep 2025 06:00:41 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical's CT:VQ™ receives FDA 510(k) clearance; First-and-only CT-based VQ technology http://www.streetinsider.com/Press+Releases/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html <div class="xn-content"> <p class="prntac"><b>Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT</b></p> <p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>Sept. 4, 2025</chron></span> /PRNewswire/ -- 4DMedical, a leader in advanced respiratory imaging, today announces <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) 510(k) clearance for CT:VQ™, the world's first and only non-contrast, ventilation–perfusion (VQ) imaging solution. In parallel, the <span>U.S. Centers for Medicare & Medicaid Services</span> (CMS) has confirmed reimbursement for CT:VQ under Category III CPT codes; this payment is in addition to existing reimbursement for the underlying chest CT.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html Thu, 04 Sep 2025 06:00:00 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical's CT:VQ™ receives FDA 510(k) clearance; First-and-only CT-based VQ technology http://www.streetinsider.com/Press+Releases/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html <div class="xn-content"> <p class="prntac"><b>Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT</b></p> <p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>Sept. 4, 2025</chron></span> /PRNewswire/ -- 4DMedical, a leader in advanced respiratory imaging, today announces <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) 510(k) clearance for CT:VQ™, the world's first and only non-contrast, ventilation–perfusion (VQ) imaging solution. In parallel, the <span>U.S. Centers for Medicare & Medicaid Services</span> (CMS) has confirmed reimbursement for CT:VQ under Category III CPT codes; this payment is in addition to existing reimbursement for the underlying chest CT.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html Thu, 04 Sep 2025 06:00:00 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical's CT:VQ™ receives FDA 510(k) clearance; First-and-only CT-based VQ technology http://www.streetinsider.com/Press+Releases/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html <div class="xn-content"> <p class="prntac"><b>Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT</b></p> <p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>Sept. 4, 2025</chron></span> /PRNewswire/ -- 4DMedical, a leader in advanced respiratory imaging, today announces <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) 510(k) clearance for CT:VQ™, the world's first and only non-contrast, ventilation–perfusion (VQ) imaging solution. In parallel, the <span>U.S. Centers for Medicare & Medicaid Services</span> (CMS) has confirmed reimbursement for CT:VQ under Category III CPT codes; this payment is in addition to existing reimbursement for the underlying chest CT.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html Thu, 04 Sep 2025 06:00:00 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical's CT:VQ™ receives FDA 510(k) clearance; First-and-only CT-based VQ technology http://www.streetinsider.com/Press+Releases/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html <div class="xn-content"> <p class="prntac"><b>Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT</b></p> <p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>Sept. 4, 2025</chron></span> /PRNewswire/ -- 4DMedical, a leader in advanced respiratory imaging, today announces <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) 510(k) clearance for CT:VQ™, the world's first and only non-contrast, ventilation–perfusion (VQ) imaging solution. In parallel, the <span>U.S. Centers for Medicare & Medicaid Services</span> (CMS) has confirmed reimbursement for CT:VQ under Category III CPT codes; this payment is in addition to existing reimbursement for the underlying chest CT.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html Thu, 04 Sep 2025 06:00:00 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical's CT:VQ™ receives FDA 510(k) clearance; First-and-only CT-based VQ technology http://www.streetinsider.com/Press+Releases/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html <div class="xn-content"> <p class="prntac"><b>Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT</b></p> <p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>Sept. 4, 2025</chron></span> /PRNewswire/ -- 4DMedical, a leader in advanced respiratory imaging, today announces <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) 510(k) clearance for CT:VQ™, the world's first and only non-contrast, ventilation–perfusion (VQ) imaging solution. In parallel, the <span>U.S. Centers for Medicare & Medicaid Services</span> (CMS) has confirmed reimbursement for CT:VQ under Category III CPT codes; this payment is in addition to existing reimbursement for the underlying chest CT.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html Thu, 04 Sep 2025 06:00:00 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical's CT:VQ™ receives FDA 510(k) clearance; First-and-only CT-based VQ technology http://www.streetinsider.com/Press+Releases/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html <div class="xn-content"> <p class="prntac"><b>Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT</b></p> <p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>Sept. 4, 2025</chron></span> /PRNewswire/ -- 4DMedical, a leader in advanced respiratory imaging, today announces <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) 510(k) clearance for CT:VQ™, the world's first and only non-contrast, ventilation–perfusion (VQ) imaging solution. In parallel, the <span>U.S. Centers for Medicare & Medicaid Services</span> (CMS) has confirmed reimbursement for CT:VQ under Category III CPT codes; this payment is in addition to existing reimbursement for the underlying chest CT.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html Thu, 04 Sep 2025 06:00:00 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical's CT:VQ™ receives FDA 510(k) clearance; First-and-only CT-based VQ technology http://www.streetinsider.com/Press+Releases/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html <div class="xn-content"> <p class="prntac"><b>Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT</b></p> <p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>Sept. 4, 2025</chron></span> /PRNewswire/ -- 4DMedical, a leader in advanced respiratory imaging, today announces <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) 510(k) clearance for CT:VQ™, the world's first and only non-contrast, ventilation–perfusion (VQ) imaging solution. In parallel, the <span>U.S. Centers for Medicare & Medicaid Services</span> (CMS) has confirmed reimbursement for CT:VQ under Category III CPT codes; this payment is in addition to existing reimbursement for the underlying chest CT.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html Thu, 04 Sep 2025 06:00:00 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical's CT:VQ™ receives FDA 510(k) clearance; First-and-only CT-based VQ technology http://www.streetinsider.com/Press+Releases/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html <div class="xn-content"> <p class="prntac"><b>Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT</b></p> <p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>Sept. 4, 2025</chron></span> /PRNewswire/ -- 4DMedical, a leader in advanced respiratory imaging, today announces <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) 510(k) clearance for CT:VQ™, the world's first and only non-contrast, ventilation–perfusion (VQ) imaging solution. In parallel, the <span>U.S. Centers for Medicare & Medicaid Services</span> (CMS) has confirmed reimbursement for CT:VQ under Category III CPT codes; this payment is in addition to existing reimbursement for the underlying chest CT.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html Thu, 04 Sep 2025 06:00:00 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical's CT:VQ™ receives FDA 510(k) clearance; First-and-only CT-based VQ technology http://www.streetinsider.com/PRNewswire/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html <div class="xn-content"> <p class="prntac"><b>Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT</b></p> <p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>Sept. 4, 2025</chron></span> /PRNewswire/ -- 4DMedical, a leader in advanced respiratory imaging, today announces <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) 510(k) clearance for CT:VQ™, the world's first and only non-contrast, ventilation–perfusion (VQ) imaging solution. In parallel, the <span>U.S. Centers for Medicare & Medicaid Services</span> (CMS) has confirmed reimbursement for CT:VQ under Category III CPT codes; this payment is in addition to existing reimbursement for the underlying chest CT.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html Thu, 04 Sep 2025 06:00:00 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical's CT:VQ™ receives FDA 510(k) clearance; First-and-only CT-based VQ technology http://www.streetinsider.com/PRNewswire/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html <div class="xn-content"> <p class="prntac"><b>Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT</b></p> <p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>Sept. 4, 2025</chron></span> /PRNewswire/ -- 4DMedical, a leader in advanced respiratory imaging, today announces <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) 510(k) clearance for CT:VQ™, the world's first and only non-contrast, ventilation–perfusion (VQ) imaging solution. In parallel, the <span>U.S. Centers for Medicare & Medicaid Services</span> (CMS) has confirmed reimbursement for CT:VQ under Category III CPT codes; this payment is in addition to existing reimbursement for the underlying chest CT.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html Thu, 04 Sep 2025 06:00:00 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical's CT:VQ™ receives FDA 510(k) clearance; First-and-only CT-based VQ technology http://www.streetinsider.com/PRNewswire/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html <div class="xn-content"> <p class="prntac"><b>Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT</b></p> <p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>Sept. 4, 2025</chron></span> /PRNewswire/ -- 4DMedical, a leader in advanced respiratory imaging, today announces <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) 510(k) clearance for CT:VQ™, the world's first and only non-contrast, ventilation–perfusion (VQ) imaging solution. In parallel, the <span>U.S. Centers for Medicare & Medicaid Services</span> (CMS) has confirmed reimbursement for CT:VQ under Category III CPT codes; this payment is in addition to existing reimbursement for the underlying chest CT.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html Thu, 04 Sep 2025 06:00:00 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical's CT:VQ™ receives FDA 510(k) clearance; First-and-only CT-based VQ technology http://www.streetinsider.com/PRNewswire/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html <div class="xn-content"> <p class="prntac"><b>Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT</b></p> <p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>Sept. 4, 2025</chron></span> /PRNewswire/ -- 4DMedical, a leader in advanced respiratory imaging, today announces <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) 510(k) clearance for CT:VQ™, the world's first and only non-contrast, ventilation–perfusion (VQ) imaging solution. In parallel, the <span>U.S. Centers for Medicare & Medicaid Services</span> (CMS) has confirmed reimbursement for CT:VQ under Category III CPT codes; this payment is in addition to existing reimbursement for the underlying chest CT.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html Thu, 04 Sep 2025 06:00:00 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical's CT:VQ™ receives FDA 510(k) clearance; First-and-only CT-based VQ technology http://www.streetinsider.com/PRNewswire/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html <div class="xn-content"> <p class="prntac"><b>Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT</b></p> <p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>Sept. 4, 2025</chron></span> /PRNewswire/ -- 4DMedical, a leader in advanced respiratory imaging, today announces <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) 510(k) clearance for CT:VQ™, the world's first and only non-contrast, ventilation–perfusion (VQ) imaging solution. In parallel, the <span>U.S. Centers for Medicare & Medicaid Services</span> (CMS) has confirmed reimbursement for CT:VQ under Category III CPT codes; this payment is in addition to existing reimbursement for the underlying chest CT.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html Thu, 04 Sep 2025 06:00:00 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical's CT:VQ™ receives FDA 510(k) clearance; First-and-only CT-based VQ technology http://www.streetinsider.com/PRNewswire/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html <div class="xn-content"> <p class="prntac"><b>Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT</b></p> <p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>Sept. 4, 2025</chron></span> /PRNewswire/ -- 4DMedical, a leader in advanced respiratory imaging, today announces <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) 510(k) clearance for CT:VQ™, the world's first and only non-contrast, ventilation–perfusion (VQ) imaging solution. In parallel, the <span>U.S. Centers for Medicare & Medicaid Services</span> (CMS) has confirmed reimbursement for CT:VQ under Category III CPT codes; this payment is in addition to existing reimbursement for the underlying chest CT.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html Thu, 04 Sep 2025 06:00:00 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical's CT:VQ™ receives FDA 510(k) clearance; First-and-only CT-based VQ technology http://www.streetinsider.com/PRNewswire/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html <div class="xn-content"> <p class="prntac"><b>Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT</b></p> <p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>Sept. 4, 2025</chron></span> /PRNewswire/ -- 4DMedical, a leader in advanced respiratory imaging, today announces <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) 510(k) clearance for CT:VQ™, the world's first and only non-contrast, ventilation–perfusion (VQ) imaging solution. In parallel, the <span>U.S. Centers for Medicare & Medicaid Services</span> (CMS) has confirmed reimbursement for CT:VQ under Category III CPT codes; this payment is in addition to existing reimbursement for the underlying chest CT.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html Thu, 04 Sep 2025 06:00:00 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 4DMedical's CT:VQ™ receives FDA 510(k) clearance; First-and-only CT-based VQ technology http://www.streetinsider.com/PRNewswire/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html <div class="xn-content"> <p class="prntac"><b>Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT</b></p> <p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>Sept. 4, 2025</chron></span> /PRNewswire/ -- 4DMedical, a leader in advanced respiratory imaging, today announces <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) 510(k) clearance for CT:VQ™, the world's first and only non-contrast, ventilation–perfusion (VQ) imaging solution. In parallel, the <span>U.S. Centers for Medicare & Medicaid Services</span> (CMS) has confirmed reimbursement for CT:VQ under Category III CPT codes; this payment is in addition to existing reimbursement for the underlying chest CT.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/4DMedical%27s+CT%3AVQ%E2%84%A2+receives+FDA+510%28k%29+clearance%3B+First-and-only+CT-based+VQ+technology/25294565.html Thu, 04 Sep 2025 06:00:00 -0500 4DX A.06822034 A.11608963 A.60012014 O.00638181 O.05010326 O.16661101 O.20026344 Form D 4DMedical Ltd http://www.streetinsider.com/SEC+Filings/Form++D++++++++++4DMedical+Ltd++++++++++++++++++++++++/25023821.html si-local-file:///var/storage/secattach/20250707/25023821.html http://www.streetinsider.com/SEC+Filings/Form++D++++++++++4DMedical+Ltd++++++++++++++++++++++++/25023821.html Mon, 07 Jul 2025 17:13:00 -0500 4DX FDMDF O.16661101